Recombinant M. tuberculosis inhA (Enoyl-ACP Reductase, NADH-Dependent), E. coli Expression

Recombinant Mycobacterium tuberculosis inhA is a high-purity enzyme expressed in E. coli, widely used in tuberculosis research and drug discovery. inhA is a key NADH-dependent enoyl-ACP reductase involved in mycolic acid biosynthesis, making it a critical target for anti-tuberculosis drug development. This recombinant protein is ideal for enzymatic assays, inhibitor screening, and mechanistic studies.

Key Features:

• Recombinant M. tuberculosis origin, expressed in E. coli
• High purity suitable for in vitro enzymatic and biochemical studies
• Supplied as 20 µg of protein for experimental use
• Supports research on tuberculosis, mycolic acid biosynthesis, and drug targeting